| Title |
Allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia (ALL) in first complete remission
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2011
|
| DOI | 10.1002/14651858.cd008818.pub2 |
| Pubmed ID | |
| Authors |
Joseph Pidala, Benjamin Djulbegovic, Claudio Anasetti, Mohamed Kharfan‐Dabaja, Ambuj Kumar |
| Abstract |
Consolidation chemotherapy, autologous hematopoietic cell transplantation (HCT) and allogeneic HCT represent potential treatment alternatives for post-remission therapy in adult acute lymphoblastic leukemia (ALL), but there is genuine uncertainty regarding the optimal approach. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Malaysia | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 1 | <1% |
| United Kingdom | 1 | <1% |
| Unknown | 117 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 15 | 13% |
| Student > Master | 14 | 12% |
| Student > Bachelor | 13 | 11% |
| Researcher | 12 | 10% |
| Student > Postgraduate | 8 | 7% |
| Other | 25 | 21% |
| Unknown | 32 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 54 | 45% |
| Nursing and Health Professions | 9 | 8% |
| Biochemistry, Genetics and Molecular Biology | 4 | 3% |
| Psychology | 4 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
| Other | 6 | 5% |
| Unknown | 40 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 October 2011.
All research outputs
#17,348,916
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#10,493
of 11,499 outputs
Outputs of similar age
#101,744
of 144,881 outputs
Outputs of similar age from Cochrane database of systematic reviews
#109
of 125 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 6th percentile – i.e., 6% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,881 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 125 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.